المصدر: Zacks Investment Research
وكالة أنباء
الأسهم
أهمية متوسطة

BAYRY Beats on Q2 Earnings, Crop Science Business Boosts Growth
Bayer tops Q2 estimates as Crop Science and fast-growing drugs offset pressure from patent-expired brands, while reaffirming its 2026 outlook.
الرموز ذات الصلة
1
B
BAYRY
BAYRY
المصدر: Zacks Investment Research
زيارة المصدر